HOME - Companies - News
 
 
23 February 2022

Envista and VItaldent extend their partnership

Katherine E. Pfaff


Dental brands supply company, Envista Holdings Corporation, and Vitaldent Group, a DSO based in Spain, have opted to continue their partnership. Under the agreement, Envista becomes the preferred supplier of clear aligners and implants, which are Spark and Nobel Biocare, respectively.

"This agreement reinforces Vitaldent Group's commitment to the quality of all materials used in its treatments, as well as the company's efforts to create solid and stable relationships with leading suppliers in the oral health sector," said Clara Esteban, medical director at Vitaldent.

Vitaldent is committed to utilizing the industry’s best technology, and providing high quality care and products, according to the company. Vitaldent has had a relationship with Nobel Biocare and its parent company, Ormco, dating back to 2009 and 2011, respectively. 

"While Vitaldent continues successfully executing their strong growth and developments plans, they remain focused and always committed on delivering our common target of achieving the best possible clinical outcomes for patients,” said Javier Vidal, vice president at Nobel Biocare. “For Vitaldent, a key driver to accomplish this purpose has always been to introduce the most innovative technologies and latest and more advanced dental treatments available in the dental industry.  We are proud to extend our existing partnership for the next three years as the preferred supplier in the implant field, providing Nobel Biocare’s latest products and services to ensure the highest quality of dental care in the dental offices." 


Source:  https://www.prnewswire.com/news-releases/envista-renews-commercial-partnership-with-vitaldent-group-301476787.html


Related articles

Envista Holdings Corporation (NYSE: NVST) (“Envista”) today announced that the company will hold an Investor Day on Thursday, September 17, from 9:00 a.m.


Envista Holdings Corporation (NYSE: NVST) (“Envista”) recently announced that the company will participate in the 8th Annual Evercore Healthcare Conference. The fireside chat will take place on...


Envista Holdings Corporation announced that the company will participate in the Stifel 2025 Jaws & Paws Conference. The fireside chat will take place on Wednesday, May 28, 2025, from 1:50–2:20...


Envista Holdings Corporation (NYSE: NVST) ("Envista") proudly announced that in 2024, the Envista Smile Project (Smile Project) contributed $1.8 million to further its mission of enhancing oral...


Envista Holdings Corporation has announced its financial results for Q4 2024, showing steady performance despite a transitional year. CEO Paul Keel emphasized the company’s progress in operational...


Read more

Investigational cytology test is designed to help clinicians assess suspicious oral lesions with a quantitative index.


The Delta Dental Community Care Foundation, the philanthropic arm of Delta Dental of California and its affiliates, announced $16.3 million in Access to Care Grant funding, continu


(Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that the Company will present at the followin


Twenty Florida high school students recently visited the UF College of Dentistry, or UFCD, for a day of programming designed to help them explore potential careers in dentistry.


This peer-reviewed periodontology article summarizes clinical evidence from Journal of periodontology (2026). It focuses on findings that may help dental professionals evaluate treatment decisions,...


 
 
 
 

 
 
 
 

Most popular

 
 

Events